No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:173070000-173077800 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
2 |
chr2:173070200-173078600 |
Weak transcription |
iPS-20b Cell Line |
embryonic stem cell
|
3 |
chr2:173070600-173076800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
4 |
chr2:173070600-173077600 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|
5 |
chr2:173071800-173074600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
6 |
chr2:173072000-173074800 |
Enhancers |
Fetal Intestine Small |
intestine
|
7 |
chr2:173072400-173074400 |
Enhancers |
Fetal Muscle Leg |
muscle
|
8 |
chr2:173072400-173074800 |
Enhancers |
Fetal Intestine Large |
intestine
|
9 |
chr2:173072400-173075800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
10 |
chr2:173072600-173074400 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
11 |
chr2:173072600-173074600 |
Enhancers |
Ovary |
ovary
|
12 |
chr2:173072600-173084200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
13 |
chr2:173072800-173074800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
14 |
chr2:173072800-173075600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
15 |
chr2:173073000-173073800 |
Enhancers |
HUVEC |
blood vessel
|
16 |
chr2:173073000-173074800 |
Enhancers |
HMEC |
breast
|
17 |
chr2:173073200-173074000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
18 |
chr2:173073200-173074000 |
Enhancers |
Right Atrium |
heart
|
19 |
chr2:173073200-173074000 |
Enhancers |
Small Intestine |
intestine
|
20 |
chr2:173073200-173074000 |
Enhancers |
HSMM |
muscle
|
21 |
chr2:173073200-173074200 |
Enhancers |
Fetal Lung |
lung
|
22 |
chr2:173073200-173074400 |
Enhancers |
Fetal Thymus |
thymus
|
23 |
chr2:173073200-173074600 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
24 |
chr2:173073200-173074600 |
Enhancers |
Placenta |
Placenta
|
25 |
chr2:173073200-173074600 |
Enhancers |
Spleen |
Spleen
|
26 |
chr2:173073200-173074600 |
Enhancers |
Osteobl |
bone
|
27 |
chr2:173073200-173074800 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
28 |
chr2:173073200-173074800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
29 |
chr2:173073400-173074000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
30 |
chr2:173073400-173074000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
31 |
chr2:173073400-173074200 |
Enhancers |
HSMMtube |
muscle
|
32 |
chr2:173073400-173074200 |
Weak transcription |
NHLF |
lung
|
33 |
chr2:173073400-173074600 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
34 |
chr2:173073400-173074600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
35 |
chr2:173073400-173076200 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
36 |
chr2:173073400-173080400 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
37 |
chr2:173073600-173074000 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
38 |
chr2:173073600-173074200 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
39 |
chr2:173073600-173074400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
40 |
chr2:173073600-173074400 |
Enhancers |
NH-A |
brain
|
41 |
chr2:173073600-173074600 |
Enhancers |
NHEK |
skin
|
42 |
chr2:173073600-173075400 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|